Stenocare AS (OCSE:STENO) Debt-to-Asset : 0.14 (As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Stenocare AS Debt-to-Asset?

Stenocare AS's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was kr0.86 Mil. Stenocare AS's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was kr2.89 Mil. Stenocare AS's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Sep. 2024 was kr26.27 Mil. Stenocare AS's debt to asset for the quarter that ended in Sep. 2024 was 0.14.

Stenocare AS Debt-to-Asset Historical Data

The historical data trend for Stenocare AS's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stenocare AS Debt-to-Asset Chart

Stenocare AS Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Asset

Get a 7-Day Free Trial

0.03

0.28

0.25

Stenocare AS Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Debt-to-Asset	Get a 7-Day Free Trial															0.24	0.25	0.22	0.26	0.14

Competitive Comparison of Stenocare AS's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Stenocare AS's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Stenocare AS's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Stenocare AS's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Stenocare AS's Debt-to-Asset falls into.

Stenocare AS Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Stenocare AS's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(8.746	+	0.936)	/	38.121
	=	0.25

Stenocare AS's Debt-to-Asset for the quarter that ended in Sep. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0.858	+	2.889)	/	26.27
	=	0.14

Stenocare AS (OCSE:STENO) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Stenocare AS Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Stenocare AS's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Stenocare AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Stenocare AS (OCSE:STENO) » Definitions » Debt-to-Asset

Traded in Other Exchanges

S7C:Germany

Address

Nyholmsvej 4, Randers NØ, DNK, 8930

Website

https://www.stenocare.com

Stenocare AS is a Danish company engaged in the cultivation and production of medical cannabis products through pharmacies and hospitals. The Company's business operations include the distribution and sales of imported products to several markets which also includes local cultivation and production of its medical cannabis products. Stenocare is well positioned to become a market leader in Denmark and a vendor in Europe. The Company is a supplier of medical cannabis oil for patients in Denmerk, Sweden, UK, Australia and Norway. It has an indoor production facility for the cultivation and production of medical cannabis at Randers, Denmark.

Stenocare AS Headlines

No Headlines